UK markets closed

Denali Therapeutics Inc. (DNLI)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
25.23+1.07 (+4.43%)
At close: 04:00PM EDT
25.23 0.00 (0.00%)
After hours: 04:02PM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2021
31/12/2020
31/12/2019
31/12/2018
Total revenue
82,879
48,661
335,659
26,678
129,160
Operating expenses
Research development
291,244
265,353
212,615
193,382
143,183
Selling general and administrative
82,664
79,059
60,326
46,480
32,349
Total operating expenses
373,908
344,412
272,941
239,862
175,532
Operating income or loss
-291,029
-295,751
62,718
-213,184
-46,372
Income before tax
-286,335
-291,156
71,959
-197,965
-36,240
Income tax expense
-
-575
823
-351
-
Income from continuing operations
-285,760
-290,581
71,136
-197,614
-36,240
Net income
-285,760
-290,581
71,136
-197,614
-36,240
Net income available to common shareholders
-285,760
-290,581
71,136
-197,614
-36,240
Basic EPS
-
-
0.65
-2.07
-0.39
Diluted EPS
-
-
0.63
-2.07
-0.39
Basic average shares
-
-
108,974
95,608
92,622
Diluted average shares
-
-
112,703
95,608
92,622
EBITDA
-
-287,158
71,249
-205,193
-38,957